FTC's Merger Concerns Remain Despite Amgen’s ‘Bare Commitment’ Not To Bundle Horizon Drugs

 
• By Brenda Sandburg
FTC building
The FTC wants a preliminary injunction to block Amgen's acquisition of Horizon. • Source: Shutterstock

More from Legal & IP

More from Pink Sheet